Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denise Wootten

Showing results (21-30 of 120) with videos related to

Pageof 12
Sort By:
Journal of the American Chemical Society|November 5, 2016
β-Arrestin-Biased Agonists of the GLP-1 Receptor from β-Amino Acid Residue Incorporation into GLP-1 AnaloguesMarlies V Hager, Lisa M Johnson, Denise Wootten, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 30, 2015
Differential impact of amino acid substitutions on critical residues of the human glucagon-like peptide-1 receptor involved in peptide activity and small-molecule allosteryCassandra Koole, Denise Wootten, John Simms, et al.
Frontiers in Molecular Biosciences|September 13, 2021
Exploring Ligand Binding to Calcitonin Gene-Related Peptide ReceptorsGiuseppe Deganutti, Silvia Atanasio, Roxana-Maria Rujan, et al.
Journal of Molecular and Cellular Cardiology|March 14, 2025
Advances in incretin therapies for targeting cardiovascular disease in diabetesTimothy D Roberts, Dana S Hutchinson, Denise Wootten, et al.
International Journal of Molecular Sciences|July 28, 2022
Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of ReceptorsJessica Lu, Sarah J Piper, Peishen Zhao, et al.
Molecular Endocrinology (Baltimore, Md.)|July 19, 2013
Minireview: Signal bias, allosterism, and polymorphic variation at the GLP-1R: implications for drug discoveryCassandra Koole, Emilia E Savage, Arthur Christopoulos, et al.
Biochemical Pharmacology|May 31, 2026
In vitro pharmacological profile of the TSH receptor-stimulating autoantibodies, M22 and K1-18Huong T M Nguyen, Elliot Gerrard, Ryan Strachan, et al.
Cell Reports|July 14, 2021
Structure and dynamics of semaglutide- and taspoglutide-bound GLP-1R-Gs complexesXin Zhang, Matthew J Belousoff, Yi-Lynn Liang, et al.
Nature Communications|May 23, 2024
Impact of secretin receptor homo-dimerization on natural ligand bindingKaleeckal G Harikumar, Sarah J Piper, Arthur Christopoulos, et al.
Molecular Pharmacology|May 28, 2011
Polymorphism and ligand dependent changes in human glucagon-like peptide-1 receptor (GLP-1R) function: allosteric rescue of loss of function mutationCassandra Koole, Denise Wootten, John Simms, et al.
Pageof 12

Showing results (21-30 of 120) with videos related to

Sort By:
Pageof 12
Journal of the American Chemical Society|November 5, 2016
β-Arrestin-Biased Agonists of the GLP-1 Receptor from β-Amino Acid Residue Incorporation into GLP-1 AnaloguesMarlies V Hager, Lisa M Johnson, Denise Wootten, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 30, 2015
Differential impact of amino acid substitutions on critical residues of the human glucagon-like peptide-1 receptor involved in peptide activity and small-molecule allosteryCassandra Koole, Denise Wootten, John Simms, et al.
Frontiers in Molecular Biosciences|September 13, 2021
Exploring Ligand Binding to Calcitonin Gene-Related Peptide ReceptorsGiuseppe Deganutti, Silvia Atanasio, Roxana-Maria Rujan, et al.
Journal of Molecular and Cellular Cardiology|March 14, 2025
Advances in incretin therapies for targeting cardiovascular disease in diabetesTimothy D Roberts, Dana S Hutchinson, Denise Wootten, et al.
International Journal of Molecular Sciences|July 28, 2022
Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of ReceptorsJessica Lu, Sarah J Piper, Peishen Zhao, et al.
Molecular Endocrinology (Baltimore, Md.)|July 19, 2013
Minireview: Signal bias, allosterism, and polymorphic variation at the GLP-1R: implications for drug discoveryCassandra Koole, Emilia E Savage, Arthur Christopoulos, et al.
Biochemical Pharmacology|May 31, 2026
In vitro pharmacological profile of the TSH receptor-stimulating autoantibodies, M22 and K1-18Huong T M Nguyen, Elliot Gerrard, Ryan Strachan, et al.
Cell Reports|July 14, 2021
Structure and dynamics of semaglutide- and taspoglutide-bound GLP-1R-Gs complexesXin Zhang, Matthew J Belousoff, Yi-Lynn Liang, et al.
Nature Communications|May 23, 2024
Impact of secretin receptor homo-dimerization on natural ligand bindingKaleeckal G Harikumar, Sarah J Piper, Arthur Christopoulos, et al.
Molecular Pharmacology|May 28, 2011
Polymorphism and ligand dependent changes in human glucagon-like peptide-1 receptor (GLP-1R) function: allosteric rescue of loss of function mutationCassandra Koole, Denise Wootten, John Simms, et al.
Pageof 12